QIAGEN N.V. to Release Results for Q2 2022 and Hold Webcast
July 07 2022 - 6:00AM
Business Wire
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA)
announced its plans to release results for the second quarter of
2022.
Press release date / time: Wednesday, July 27, shortly after
22:05 Frankfurt time / 21:05 London time / 16:05 New York
time.
Conference call date / time: Thursday, July 28, at 15:30
Frankfurt time / 14:30 London time / 09:30 New York time.
Three options for joining the
conference call
Register for call back
connection
Click here:
Connect
Me
Service available 15 minutes before call
start
Dial-in by phone
+1 646 828 8075 (U.S.)
+44 (0)330 165 4012 (UK)
+49 (0)69 22222 5197 (GER)
To avoid waiting time, please join the
event conference 5-10 minutes prior to the start time.
Conference ID: 3332305
Access the audio webcast
Click here:
Access
Webcast
A conference call replay will be available by using the
following link: https://globalmeet.webcasts.com/starthere.jsp?ei=1556677&tp_key=b55d95ed6e
Contact: IR@qiagen.com
About QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading
global provider of Sample to Insight solutions that enable
customers to gain valuable molecular insights from samples
containing the building blocks of life. Our sample technologies
isolate and process DNA, RNA and proteins from blood, tissue and
other materials. Assay technologies make these biomolecules visible
and ready for analysis. Bioinformatics software and knowledge bases
interpret data to report relevant, actionable insights. Automation
solutions tie these together in seamless and cost-effective
workflows. QIAGEN provides solutions to more than 500,000 customers
around the world in Molecular Diagnostics (human healthcare) and
Life Sciences (academia, pharma R&D and industrial
applications, primarily forensics). As of March 31, 2022, QIAGEN
employed more than 6,000 people in over 35 locations worldwide.
Further information can be found at http://www.qiagen.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220707005323/en/
John Gilardi Vice President, Head of Corporate Communications
and Investor Relations +49 2103 29 11711 +1 240 686 2222 Email:
ir@qiagen.com
Phoebe Loh Senior Director Investor Relations +49 2103 29 11457
Email: ir@qiagen.com
Qiagen NV (NYSE:QGEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Qiagen NV (NYSE:QGEN)
Historical Stock Chart
From Apr 2023 to Apr 2024